NOI - 4D-Nucleofector Core Unit and X Unit

The National Institutes of Health, Office of the Director, Office of Acquisitions, intends to award a firm-fixed-price purchase order on a non-competitive basis to Lonza Walkersville, Inc. for one 4D-Nucleofector Core Unit and one 4D-Nucleofector X Unit with one-year warranty extensions, with responses due November 5, 2026 at 1:00 PM EDT. This is a brand-name-only procurement under FAR 12.603 and FAR 6.302-3(a)(2)(ii), conducted as a Notice of Intent for a non-competitive combined synopsis/solicitation not expected to exceed the simplified acquisition threshold. All responsible sources may submit capability statements and quotations for consideration.

Delivery is to National Institutes of Health, Building 10, Room 6S257, 9000 Rockville Pike, Bethesda, Maryland 20892, as soon as possible after receipt of order on weekdays under F.O.B. Destination terms. The equipment will introduce plasmids, CRISPR/Cas9 components, guide RNAs, reporter constructs, and genetic material into primary cells and difficult-to-transfect cell types to maintain continuity with validated experimental conditions and support reproducibility of ongoing studies. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing, with a small business size standard of 1,000 employees; this requirement is not set aside for small business. Evaluation criteria include technical capability to provide the exact specified equipment, documentation of manufacturer or authorized-reseller status with manufacturer-supported warranty coverage, delivery timeframe, and price. Used, refurbished, remanufactured, or gray-market equipment will not satisfy the requirement. Respondents must provide unit pricing, delivery timeframe, F.O.B. point, prompt payment discount terms, and product/catalog/part numbers, and must submit the Unique Entity Identifier, Taxpayer Identification Number, business size certification, and proof of active registration in SAM.